secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytosorbents Corp (CTSO)
CIK:        0001175151
Form:       8-K
Filed at:   2025-04-17T23:59:59+00:00
Accession:  0001104659-25-036004
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoSorbents appoints Melanie Grossman as VP & Corp Controller; issues inducement options and RSUs
--------------------------------------------------------------------------------

- Appointment of Melanie Grossman as VP and Corporate Controller, effective April 14, 2025.
- Inducement grant includes 25,000 options at $0.99 exercise price, 10-year term, vesting 50% year 1 then 25% annually.
- Also granted 35,000 signing RSUs (change-of-control or 4-year cliff) and 35,000 change-of-control RSUs.
- Grossman brings 25 years of experience; previously SVP & Group Controller at Staffing 360 and auditor at Ernst & Young.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175151/000110465925036004/0001104659-25-036004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175151/000110465925036004/tm2512549d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-036004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer